The Lancet Haematology · 2024 · 48 citations · 18 references
MedicineHematologyPharmacotherapyTransfusion MedicineMyelodysplastic SyndromesTransfusion SupportErythropoiesis-stimulating Agent UseErythropoiesis-stimulating TherapyHigher-risk Myelodysplastic SyndromesLower-risk Myelodysplastic SyndromesMyelodysplastic Syndrome TherapyMyelodysplastic Syndrome TreatmentPrimary Effect AnalysisPrimary Outcome Analysis
18
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Peter L. Greenberg, Heinz Tuechler, Julie Schanz et al. · Blood · 2012 · 3.1K citations · Full text